Skip to main content
Clinical Trials/NCT03459001
NCT03459001CompletedNot Applicable

A Prospective, Observational Study to Evaluate the Use of a High Calorie, High Protein Tube Feeding Product in an Adult Population With or at Risk of Malnutrition

Abbott Nutrition9 sites in 1 country17 target enrollmentStarted: June 8, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
17
Locations
9
Primary Endpoint
Tube Feed Product Compliance

Study Overview

Brief Summary

This prospective, observational study is designed to observe the use of a high calorie, high protein tube feed product in adults that are malnourished or at risk of malnutrition, as assessed by a clinician, and have been placed on a nutritional care plan which includes a tube feeding formula, per standard of care.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Malnourished or at risk for malnutrition based on the Malnutrition Universal Tool (MUST) score ≥
  • Under the care of a health care professional for malnutrition or at risk of malnutrition and has been prescribed the study formula.
  • Requires and agrees to be tube fed the enteral feeding product for at least 16 consecutive days as their sole-source of nutritional intake.
  • Free living in the community or is residing in a nursing home.
  • Conforms to the requirements set forth on the study product label.

Exclusion Criteria

  • Currently taking or has taken antibiotics within 2 weeks prior to enrollment.
  • Consuming food PO.
  • Current active cancer and the study physician determines that the subject is not suitable for the study.
  • History of diabetes mellitus as evidenced by taking anti-hyperglycemic medications or by self-reported dietary modification for control of diabetes mellitus.
  • Renal or liver failure.
  • Pregnant as demonstrated by self-report.
  • Severe auto immune disease (per physician's discretion) and is on immuno-modulating therapy.
  • History of allergy to any of the ingredients in the study product.
  • Active Human Immunodeficiency Virus (HIV).
  • Known dementia, brain metastases, eating disorders, history of significant neurological or psychiatric disorder, or any other psychological condition that may interfere with study product consumption and does not have a caregiver who can assist them with adherence to the study protocol.
  • Condition that is contraindicated to tube feeding the study product.
  • Taking part in a non-approved clinical trial.

Outcomes

Primary Outcomes

Tube Feed Product Compliance

Time Frame: Day 1 to Day 20

Average Daily Intake and Proportion of Days Compliant

Secondary Outcomes

  • Adverse Events(Day 0 to Day 20)
  • Body Mass Index(Day 0 to Day 20)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (9)

Loading locations...

Similar Trials